http://www.blueprintmedicines.com
Blueprint Medicines Corporation Company Intro
Protein kinases (enzymes that modify the functions of proteins) are critical to controlling biochemical pathways and are involved in many hallmarks of tumor biology – yet currently approved drugs focus on less than 5% of known kinases.
Industry
Healthcare
Blueprint Medicines Corporation Headquaters
45 Sidney Street
Cambridge,02139
United States
Blueprint Medicines Corporation Share price
02 Dec 2021 09:43 GMT
$97.70
1.5 (1.56 %)
Blueprint Medicines Corporation Market cap
$5.603 B
WMC RANKING
2021
Blueprint Medicines Corporation # 85
BiotechnologyLatest Blueprint Medicines Corporation News
01 Dec 2021
Here is why ImmunoGen Inc. (IMGN) stock went down in the after-hours after good early gains?
ImmunoGen Inc. (IMGN) shares surged 29.89% in regular trading but later declined 5.03% in after-hours on Tuesday and closed at $5.86.
01 Dec 2021
FY2025 Earnings Estimate for Blueprint Medicines Co. Issued By Wedbush (NASDAQ:BPMC)
Blueprint Medicines Co. (NASDAQ:BPMC) - Analysts at Wedbush dropped their FY2025 earnings estimates for Blueprint Medicines in a report released on Monday,...
01 Dec 2021
-$0.75 EPS Expected for Blueprint Medicines Co. (NASDAQ:BPMC) This Quarter
Wall Street analysts predict that Blueprint Medicines Co. (NASDAQ:BPMC) will announce earnings per share of ($0.75) for the current quarter, Zacks reports.
WMC Market Score
WMC Market to Revenue Score
Blueprint Medicines Corporation Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Blueprint Medicines Corporation | USD | $809,144 | $486,514 | $325,123 | $56,030B | 85 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $685,150B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $515,660B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ | 3 |
| Incyte Corporation | USD | $2,702,913 | $2,048,306 | $478,480 | $148,930B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Blueprint Medicines Corporation Social Followers vs Top 4 Industry Competitors
Blueprint Medicines Corporation Post vs Top 4 Industry Competitors
Blueprint Medicines Corporation Digital Footprint By Size vs Top 4 Industry Competitors
Blueprint Medicines Corporation Digital Footprint By Change Rate vs Top 4 Industry Competitors
Blueprint Medicines Corporation WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Blueprint Medicines Corporation | 8.80 | 10.99 | 0.06 | 0 | 0 | 0 | 4.36 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 100 | 0 | 0 | 54.46 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 86 | 0 | 0 | 50.16 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 60 | 0 | 0 | 100 |
| Incyte Corporation | 29.39 | 5.03 | 0.04 | 2 | 0 | 0 | 2.88 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
